NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/04/2025
Back to search
Official data from USPTO
THERAPANACEA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THERAPANACEA
ST13
US500000079281530Class
9, 38, 42, 44
Filing
79281530
Registration
6624153
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
07/05/2025
Trademark type
Word
Nice classes
9, 38, 42, 44
Filing date
11/26/2019
Registration date
01/25/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/25/2022
Last transaction
07/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
VALLILLO, MELISSA
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
THERAPANACEA
Representatives
Jess M. Collen Collen IP Intellectual Property Law, P.C.
Technical classification
Nice Classes
Class 9Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
image recording apparatus; image transmission apparatus; image reproduction apparatus; digital recording mediavideo recorders; diagnostic apparatus not for medical useapparatus for the detection of pathogens for laboratory or research use; downloadable software for use in the field of cancer therapy and pathogen detection; recorded software for use in determining treatment protocols in the field of cancer therapy; downloadable artificial intelligence software in particular for use in determining treatment protocols in relation to precision radiotherapy treatment of cancer; downloadable software applications for use in medical data analysis; downloadable software platforms for use in analysis of medical outcomes; recorded or downloadable embedded operating software for X-ray CT scanners; downloadable tablet computer software and software applications for use in medical data analysis; recorded virtual reality software for use in guiding surgical instruments during surgery; data storage devices for use in the field of cancer management; teaching apparatus and simulatorselectronic clinicians training simulators
Class 38
provision of access to databases; transmission of medical digital files; transmission of digital files for use in the receptioncare and accompaniment of sick persons and of patients through computer applications and dynamic display screensa website accessible online particularly via a tabletmobile telephone or computervia a social network and via interactive orientation terminals; all the foregoing in the field of cancer research and cancer treatment
Class 42
Scientific and medical research; research and development of new therapies for cancer treatment; scientific research in the medical fieldin particular relating to cancer treatment; software design using artificial intelligence in the field of cancer treatment aimed at developing precision radiation therapy for improving the clinical effects of treatment; computer system analysis; computer system design; computer hardware design and development services provided by consultants; digitization of documents; software as a service (SaaS) services featuring software for use in analyzing medical research data; cloud computing featuring software for use in scientific data management; information technology (IT) consultancy; server hosting; electronic data storage; all the foregoing in the medical fieldin particular for cancer treatment
Class 44
medical analysis servicesmedical diagnostic testing services; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; laboratory services relating to treatment of personsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical imagingradiotherapybrachytherapy and medical dosimetry services for the treatment of cancer; information in the field of cancer treatment; medical services for cancer treatment; medical analysis services for cancer diagnosis; providing cancer screening services; information in the fields of healthcancer and cancer treatmentrecovery and survival via a global computer network; medical evaluation and medical diagnosis of cancer; prognosis evaluation in cancer therapy
Publications
History of USPTO decisions and trademark events.
43 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/29/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/18/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/29/2022
FIMP
FINAL DISPOSITION PROCESSED
06/29/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/25/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/25/2022
GPNX
NOTIFICATION PROCESSED BY IB
11/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
11/09/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/20/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/24/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/10/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/30/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/25/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/25/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/02/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/22/2020
GNSL
LETTER OF SUSPENSION E-MAILED
10/22/2020
CNSL
SUSPENSION LETTER WRITTEN
10/22/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/08/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/08/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2020
RFNT
REFUSAL PROCESSED BY IB
05/01/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/16/2020
RFRR
REFUSAL PROCESSED BY MPU
04/15/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/28/2020
CNRT
NON-FINAL ACTION WRITTEN
03/27/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/27/2020
DOCK
ASSIGNED TO EXAMINER
03/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/23/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/19/2020
Continuous trademark protection
Get notified about every new filing that threatens THERAPANACEA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.